Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial-Reference-Cited by-同舟云学术

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease – Additional particular aspects of the Pro(a)LiFe multicenter trial

Published:2015-05 Issue: Volume:18 Page:35-40
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Klingel Reinhard,Heibges Andreas,Fassbender Cordula

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference12 articles.

1. Lipoprotein apheresis in patients with maximally tolerated lipid lowering therapy, Lp(a)-hyperlipoproteinemia and progressive cardiovascular disease – prospective observational multicenter study;Leebmann;Circulation,2013

2. Lipoprotein(a) as a cardiovascular risk factor: current status;Nordestgaard;Eur Heart J,2010

3. Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events;Jaeger;Nat Clin Pract Cardiovasc Med,2009

4. Use of a reference material proposed by the international federation of clinical chemistry and laboratory medicine to evaluate analytical methods for the determination of plasma lipoprotein(a);Marcovina;Clin Chem,2000

5. Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions;Marcovina;Clin Chem,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The German Lipoprotein Apheresis Registry—Summary of the ninth annual report;Therapeutic Apheresis and Dialysis;2022-12

2. Lipoprotein apheresis efficacy and challenges: single center experience;Hematology, Transfusion and Cell Therapy;2021-03

3. Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia;Current Atherosclerosis Reports;2020-09-18

4. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre;Cardiology Journal;2020-01-22

5. One year follow-up of patients with reduced left ventricular ejection fraction (LVEF) on lipoprotein apheresis;Atherosclerosis Supplements;2019-12